These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11345109)

  • 1. The role of contrast-enhanced sonography for radiofrequency ablation of liver tumors.
    Liu JB; Goldberg BB; Merton DA; Rawool NM; Needleman L; Forsberg F
    J Ultrasound Med; 2001 May; 20(5):517-23. PubMed ID: 11345109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of high intensity focused ultrasound combined with SonoVue on rabbit VX2 liver tumors: assessment with conventional gray-scale US, conventional color/power Doppler US, contrast-enhanced color Doppler US, and contrast-enhanced pulse-inversion harmonic US.
    Luo W; Zhou X; He G; Li Q; Zheng X; Fan Z; Liu Q; Yu M; Han Z; Zhang J; Qian Y
    Ann Surg Oncol; 2008 Oct; 15(10):2943-53. PubMed ID: 18612702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
    Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
    J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
    Kan X; Zhang Y; Zheng C; Li L; Chen J; Wu Y; Guo T; Xiong B
    J Vasc Interv Radiol; 2016 Jul; 27(7):1077-1085.e2. PubMed ID: 27117950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors.
    Zou X; Liu Q; Zhou X; He G; Yu M; Han Z; Meng X; Su H
    Acta Radiol; 2013 Mar; 54(2):181-7. PubMed ID: 23482351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radio-frequency ablation of VX2 rabbit tumors: assessment of completeness of treatment by using contrast-enhanced harmonic power Doppler US.
    Boehm T; Malich A; Goldberg SN; Hauff P; Reinhardt M; Reichenbach JR; Müller W; Fleck M; Seifert B; Kaiser WA
    Radiology; 2002 Dec; 225(3):815-21. PubMed ID: 12461266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.
    Lee JM; Youk JH; Lee YH; Kim YK; Kim CS; Li CA
    Korean J Radiol; 2003; 4(2):124-9. PubMed ID: 12845308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim MJ; Kim SK; Jang KM; Lee JY; Lim JH
    Korean J Radiol; 2004; 5(3):185-98. PubMed ID: 15467416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
    Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
    J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray scale second harmonic imaging of acoustic emission signals improves detection of liver tumors in rabbits.
    Forsberg F; Liu JB; Merton DA; Rawool NM; Johnson DK; Goldberg BB
    J Ultrasound Med; 2000 Aug; 19(8):557-63. PubMed ID: 10944042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging.
    Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Ultrasound Med; 2015 Mar; 34(3):411-21. PubMed ID: 25715362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography?
    Zhou P; Kudo M; Minami Y; Chung H; Inoue T; Fukunaga T; Maekawa K
    Oncology; 2007; 72 Suppl 1():92-7. PubMed ID: 18087188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles.
    Kono Y; Moriyasu F; Mine Y; Nada T; Kamiyama N; Suginoshita Y; Matsumura T; Kobayashi K; Chiba T
    Invest Radiol; 1997 Feb; 32(2):120-5. PubMed ID: 9039585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
    J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.